News
Revolutionizing Clinical Trials with Precision Imaging – What Our New Partnership Means for Trial Actors
Ophthalmic clinical trials demand cutting-edge technology to drive research forward—and retinal imaging is leading the way.
That’s why we’re proud to announce our exclusive distributor partnership with Imagine Eyes, bringing the rtx1™ Adaptive Optics Retinal Camera to clinical trial sites worldwide.
This advanced technology empowers investigators with:
◼️ Unprecedented resolution – Visualize cellular and microvascular detail to reveal early microlesions and minute changes in the retina
◼️ Optimized patient selection – Through phenotyping at the microscopic level
◼️ Early signals of treatment efficacy – Detected on 5x shorter time scales
◼️ Sensitive detection of potential side effects – At the level of cells and vessel walls
◼️ Seamless global access – Through Emsere’s extensive clinical trial equipment network
Want to see this technology in action? Join Imagine Eyes’ upcoming webinar:
Title: “Tracking AMD Progression with Cellular Resolution”
🗓️ March 31, 2025
🔗 Register here: https://lnkd.in/e9rNgtfA or catch the replay on April 7th!
“By bringing the rtx1 Adaptive Optics Retinal Camera to the global research community, we can further support groundbreaking ophthalmic trials, striving to improve patient outcomes.” – Jonathan Raven, CCO, Emsere
This partnership reflects our shared commitment to accelerating ophthalmic innovation and equipping trial actors with world-class tools.